Brain-derived neurotrophic factor (BDNF) is known to modulate synapse development and plasticity, but the source of synaptic BDNF and molecular mechanisms regulating BDNF release remain unclear. Using exogenous BDNF tagged with quantum dots (BDNFQDs), we found that endocytosed BDNF-QDs were preferentially localized to postsynaptic sites in the dendrite of cultured hippocampal neurons. Repetitive neuronal spiking induced the release of BDNF-QDs at these sites, and this process required activation of glutamate receptors. Down-regulating complexin 1/2 (Cpx1/2) expression eliminated activity-induced BDNF-QD secretion, although the overall activity-independent secretion was elevated. Among eight synaptotagmin (Syt) isoforms examined, down-regulation of only Syt6 impaired activity-induced BDNF-QD secretion. In contrast, activity-induced release of endogenously synthesized BDNF did not depend on Syt6. Thus, neuronal activity could trigger the release of endosomal BDNF from postsynaptic dendrites in a Cpxand Syt6-dependent manner, and endosomes containing BDNF may serve as a source of BDNF for activity-dependent synaptic modulation.
Brain-derived neurotrophic factor (BDNF) is known to modulate synapse development and plasticity, but the source of synaptic BDNF and molecular mechanisms regulating BDNF release remain unclear. Using exogenous BDNF tagged with quantum dots (BDNFQDs), we found that endocytosed BDNF-QDs were preferentially localized to postsynaptic sites in the dendrite of cultured hippocampal neurons. Repetitive neuronal spiking induced the release of BDNF-QDs at these sites, and this process required activation of glutamate receptors. Down-regulating complexin 1/2 (Cpx1/2) expression eliminated activity-induced BDNF-QD secretion, although the overall activity-independent secretion was elevated. Among eight synaptotagmin (Syt) isoforms examined, down-regulation of only Syt6 impaired activity-induced BDNF-QD secretion. In contrast, activity-induced release of endogenously synthesized BDNF did not depend on Syt6. Thus, neuronal activity could trigger the release of endosomal BDNF from postsynaptic dendrites in a Cpxand Syt6-dependent manner, and endosomes containing BDNF may serve as a source of BDNF for activity-dependent synaptic modulation.
BDNF | endocytosis | secretion | synaptotagmin | complexin B rain-derived neurotrophic factor (BDNF), a member of neurotrophin family of secreted factors, is known to play important regulatory roles in neuronal survival and differentiation, synaptic development and plasticity, as well as many cognitive functions (1, 2) . The findings that the synthesis and secretion of neurotrophins are regulated by neuronal activity prompted the suggestion that neurotrophins may regulate activity-dependent neural plasticity in the brain (3) . Indeed, there is now substantial evidence indicating that activity-induced BDNF secretion at glutamatergic synapses is essential for long-term potentiation (LTP) (4), a cellular substrate for the learning and memory functions of neural circuits.
The BDNF protein is first synthesized in the endoplasmic reticulum as a precursor protein, prepro-BDNF, which is then converted to pro-BDNF by removal of the signal peptide and further cleaved to generate the mature BDNF (5). Immunostaining and electron microscope studies using specific antibodies to the proand mature form of BDNF showed that pro-BDNF is colocalized with mature BDNF in secretory granules in presynaptic axon terminals (6) , suggesting that the cleavage may occur in the secretory granule. However, under some experimental conditions, the processing of pro-BDNF into mature BDNF may occur extracellularly (7, 8) . The secretory granule containing BDNF and pro-BDNF could undergo exocytosis upon neuronal excitation, as readily demonstrated in cell cultures using ELISA or fluorescent protein-tagged BDNF expressed in the neuron (9, 10) . Besides secretory granules, neurotrophins within neuronal cytoplasm could also reside in endosomal compartments, resulting from endocytic uptake of extracellular neurotrophins secreted by the neuron itself or other nearby cells. Initially discovered as factors derived by target tissues, neurotrophins exert their actions via binding to neuronal surface receptors, including tropomyosin related kinase B (TrkB) and pan-neurotrophin receptor p75 (11) . Neurotrophin binding to its receptor leads to cytoplasmic signaling as well as internalization of the neurotrophin-receptor complexes. These endocytosed neurotrophin-receptor complexes remain active in the form of "signaling endosomes" that could be transported over long distances within neuronal cytoplasm to exert its regulatory functions within the neuron (12) (13) (14) (15) . In this study, we have examined the possibility that these endosomes may undergo activity-dependent exocytosis at postsynaptic dendrites, thus providing an additional source of synaptic BDNF.
To mark endosomes containing BDNF via the endocytic pathway, it is necessary to monitor BDNF trafficking in neurons. Although YFP-tagged BDNF has been used to study internalization of exogenous BDNF (16) , such fluorescent proteinlabeled BDNF was not suitable for real-time tracking of BDNFcontaining endosomes at a high spatiotemporal resolution. In this study, we used BDNF linked to quantum dots (QDs), which are fluorescent nanoparticles with excellent photostability (17) and could be tracked in live cells with high signal-to-noise ratio and over unprecedented duration. This method has been used to examine endocytic recycling of synaptic vesicles (18) and axonal transport of endosomes containing neurotrophins (19, 20) . In Significance Brain-derived neurotrophic factor (BDNF) is a secreted neurotrophin known to mediate activity-dependent synaptic plasticity. Endogenously synthesized BDNF is normally stored and transported in dense core vesicles and secreted at synapses in response to activity. However, secreted BDNF may also be endocytosed by neurons and transported within neuronal cytoplasm in the form of endosomes. By monitoring the endocytosed BDNF bound to fluorescent quantum dots (BDNF-QDs), we found that endocytosed BDNF-QDs could be preferentially localized to postsynaptic sites in cultured hippocampal neurons and became exocytosed in response to synaptic activity. This synaptic release of endocytic BDNF requires a synaptotagmin isoform distinct from that regulates the secretion of dense core vesicles, and may serve as a source for activity-dependent secretion of synaptic BDNF.
this study, we used time-lapse imaging of BDNF-QDs within cultured hippocampal neurons to monitor intracellular transport and localization of these endosomes. Furthermore, the sudden disappearance of cytoplasmic QD fluorescence in a solution containing fluorescence quencher was used to indicate the exocytosis of QD-containing endosomes. Previous studies have shown that extracellular false transmitters, soluble fluorescent markers, and membrane-bound fluorescent lipid dyes could be loaded into endosomes, which undergo exocytosis upon membrane depolarization (21) (22) (23) (24) (25) . However, whether endosomes formed by receptor-mediated endocytosis is similarly regulated by activity remains unclear. Furthermore, the Ca 2+ -dependence and the kinetics of exocytosis of different endosomal vesicle populations may be differentially regulated by distinct vesicle-associated proteins.
In the present study, we have explored the role of synaptotagmin (Syt) and complexin (Cpx) in regulating activity-induced exocytosis of BDNF-containing endosomes. As a universal cofactor in all Ca 2+ -triggered vesicular fusion reactions that have been examined (26) , Cpx is known to serve both activating and clamping functions for vesicular exocytosis, by interacting with the Ca 2+ sensor Syt and the assembled SNARE complexes at the plasma membrane (27) . Various isoforms of Syt play distinct regulatory roles in various types of neurosecretion, presumably via their differential Ca 2+ sensitivity. By manipulating the expression of various Syt and Cpx isoforms in cultured hippocampal neurons, we found that Syt6 and Cpx1/2 play essential regulatory roles in activity-dependent exocytosis of BDNF-containing endosomes. These results support the notion that BDNF-containing endosomes may serve as a source of extracellular BDNF for activity-dependent synaptic modulation and that Syt6 specifically regulates the exocytosis of BDNF-containing endosomes.
Results
Intracellular Localization of Endocytosed BDNF-QDs. To study intracellular processing and secretion of endocytosed BDNF, we used streptavidin-conjugated QDs (QD655s) (Materials and Methods and Fig. S1 ) that were linked to biotinylated BDNF. The biological activity of BDNF-QDs has been shown by induced TrkB phosphorylation in TrkB-overexpressing 3T3 cells and Erk1/2 phosphorylation in hippocampal neurons (19) . Cultured hippocampal neurons on 13-16 d in vitro (DIV) were treated with 1 nM of BDNF-QD for 10 min (Fig. 1A) . Fluorescence imaging of neurons showed many bright and blinking puncta in the soma and neurite processes. Intracellular localization of BDNF-QDs was verified by extracellular addition of a fluorescence quencher, QSY 21 carboxylic acid-succinimidyl ester (QSY21), which effectively quenched the fluorescence of extracellular BDNF-QDs that were bound to the culture substrate and cell surface (28) (Fig. S2A) . Endocytosed BDNF-QDs were observed in both dendrites and axons, which were identified as thick processes stained with microtubule-associated protein 2 (MAP2) and thin processes labeled by axon-specific marker Smi-312, respectively (Fig. 1B) . In all cases, we found that the density of BDNF-QD puncta in the dendrite was significantly higher than those in the axon. In contrast, very few internalized QDs were observed when a mixture of unmodified BDNF and QDs was used for incubating the cells (Fig. 1C) . Moreover, the number of internalized BDNFQDs was negligible when the neurons were incubated with BDNF-QDs in the presence of TrkB-Fc protein (10 μg/mL), a soluble Fc-tagged TrkB that competes with cell surface TrkB for BDNF binding (29) . Thus, internalization of BDNF-QDs depends on BDNF binding to the cell surface.
To characterize the cellular distribution of endocytosed BDNF, we fixed the neurons after 10-min BDNF-QD incubation and immunostained the cells with antibodies against the postsynaptic protein PSD95 and the synaptic vesicle-associated protein synaptophysin (Syp). We found that a subpopulation (15.6 ± 1.6%) of BDNF-QDs in the dendrite colocalized with PSD95 puncta, and 29.8 ± 3.0% of BDNF-QDs in the axon colocalized with Syp puncta (Fig. 1 D and E) . Thus, although only a minor population of BDNF-QD-containing vesicles appeared to located at synaptic sites in both dendrites and axons, the percentage is much higher than the average area occupied by PSD95 or Syp puncta along these processes (∼8%) (Fig. S3C) , suggesting preferential synaptic location of endocytosed BDNF-QDs. Additional immunostaining studies showed that ∼50% of BDNF-QDs colocalized with the early endosomal protein, EEA1 (Fig. 1F) , indicating that BDNF-QDs entered the cells through endocytosis and resided in endosomal compartments.
The intracellular distributions of endocytosed and endogenously synthesized BDNF were also compared. Neurons transfected with a BDNF-EGFP plasmid (Materials and Methods) were incubated with BDNF-QDs for 1 h, and live neurons with EGFP and QD655 fluorescence in the presence of external quencher QSY21 were examined. We found that that BDNF-EGFP distributed in both dendrites and axons in a punctate pattern similar to that of BDNF-QDs, although BDNF-QD puncta were smaller and rounder ( Fig. 1 G and H) . Moreover, BDNF-QDs and BDNF-EGFP puncta were essentially nonoverlapping, as quantitative fluorescence measurements showed no correlation between QD and EGFP fluorescence [Pearson's correlation coefficient = −0.096 ± 0.009 (SEM), n = 4 independent cultures], indicating that endocytosed and endogenously synthesized BDNF reside in distinct intracellular compartments.
Cytoplasmic Transport of Internalized BDNF-QDs. Previous work has demonstrated that BDNF/TrkB endosomes undergo dyneindependent retrograde transport in the axon toward the cell body after internalization (30) . To investigate the transport of internalized BDNF-QDs at both axons and dendrites, hippocampal neurons on 10-16 DIV were perfused with BDNF-QDs for 2 min and then QSY21-containing saline was used to perfuse the culture for 30 min before time-lapse imaging in the presence of QSY21. As shown by representative trajectories and kymographs of axonal transport of BDNF-QDs ( Fig. 2 A and B and Movie S1), the majority of transported BDNF-QDs was found to be in the retrograde direction (toward the cell body) with intermittent pauses, consistent with a previous report (19) (Fig. 2 B and C) . In contrast, BDNF-QDs in dendrites showed frequent alterations between anterograde and retrograde directions, resulting in very limited net translocation (Fig. 2D ). Many BDNF-QDs (69.8 ± 5.4% in dendrites and 64.5 ± 2.1% in axons, n = 7 neurons) were immobilized during the standard period of observation (30-60 min). The mean velocity of translocation (on-duty velocity) in both axons and dendrites was in the range of 0.1-0.3 μm/s (Fig. 2E) , consistent with active motor-driven transport.
Activity-Induced Endocytosis of BDNF-QDs. To determine whether the endocytosis of BDNF-QDs could be influenced by neuronal activity, we transfected hippocampal cultures with PSD95-GFP on 6 DIV, and then exposed the cultures on 12-15 DIV to solution containing BDNF-QDs for 10 min with or without the treatment that elevated neuronal activity. Time-lapsed imaging of neurons was performed within 10 min after the incubation with BDNF-QDs. In the absence of treatment that elevates the activity, we found that 17.2 ± 1.9% of BDNF-QDs showed colocalization with PSD95-GFP puncta (Fig. S3A) . Because this percentage is much higher than the percentage of dendritic area occupied by PSD95-GFP (7.8 ± 0.5%), internalized BDNF-QDs were not randomly distributed in the dendrite, but preferentially localized to the PSD95-GFP sites. When the neuronal activity was elevated by using BDNF-QD incubating medium containing either 45 mM KCl or 200 μM glycine, which induced depolarization or enhanced activation of NMDA receptors, respectively, the number of BDNF-QDs colocalizing with PSD95-GFP puncta was significantly increased (Fig. S3 A and C) . Thus, elevated neuronal activity enhanced either preferential BDNF-QD endocytosis at postsynaptic sites or the trapping of BDNF-QDcontaining endosomes at these sites immediately after endocytosis.
To further examine the sites of BDNF-QD internalization along the axon, we transfected neurons with Syp-GFP to mark presynaptic sites. We found that 33.8 ± 3.9% of BDNF-QDs were colocalized with Syp-GFP + sites (Fig. S3B ). The percentage of colocalization was increased to 44.0 ± 3.0% after incubation of BDNF-QDs in the presence of 45 mM KCl, suggesting activity also enhanced the localization of endocytosis BDNF-QDs at presynaptic sites. Furthermore, there was no significant increase in the total number of BDNF-QD uptake in the axon (0.032 ± 0.005/μm 2 in control vs. 0.025 ± 0.004/μm 2 in 45 mM KCl). Taken together, these results indicate that neuronal activity enhances internalization of BDNF-QDs and their localization at both pre-and postsynaptic sites. Activity-Dependent Exocytosis of BDNF-QDs at Postsynaptic Sites. To examine the exocytosis of endosomes containing BDNF-QDs, we monitored the sudden disappearance of the fluorescence of previously loaded BDNF-QDs in the presence of extracellular QSY21, which quenches the QD fluorescence after the fusion of BDNF-QD-containing endosomes with the plasma membrane (Fig. 3A) . For this study, we exposed DIV 12-16 hippocampal neurons to a solution containing BDNF-QDs for 60 min, and then perfused the culture with QSY21-containing saline and performed time-lapse imaging of the endocytosed BDNF-QDs (at sampling rate of 0.2 Hz), in the absence or presence of extracellular electrical stimulation. The axon/dendrite identity was determined by the neurite morphology and further confirmed in some cases by immunostaining with somatodendritic marker MAP2 and axonal marker Smi-312 (Fig. S4A) . The effectiveness of the electrical stimulation in triggering neuronal spiking was confirmed by fluorescence Ca 2+ imaging using the indicator calcium orange. As shown in Fig. S4B , θ-burst stimulation (TBS, 12 trains at 5-s intervals, each train consisting of 10 100-Hz bursts of 5 2-ms pulses spaced by 200 ms) resulted in immediate 30% increase in the calcium orange fluorescence, reflecting neuronal firing (31) . We found that a small fraction (12.6 ± 1.7%) of BDNF-QDs vanished after stimulation, suggesting secretion of BDNF-QD-containing endosomes at dendrites.
To further examine whether the BDNF-QD release site is located at the synapse, we transfected cultured hippocampal neurons on 5-6 DIV with vectors expressing PSD95-GFP to mark postsynaptic sites, and exposed the neurons to solution containing BDNF-QDs on 12-16 DIV for 60 min before the time-lapse imaging. We found that most PSD95-GFP puncta (95%) were immobile and colocalized or juxtaposed (within 1 pixel, 1 pixel = 267 nm) to Syp immunostaining, consistent with postsynaptic sites. Furthermore, we found that only about 9.5% of BDNF-QDs colocalized with PSD95-GFP puncta (Fig. 3B) , suggesting no apparent concentration of BDNF-QDs at PSD95-GFP sites after 1 h. However, among all PSD95-colocalized BDNF-QDs that were found to disappear during the 12-min period of experiment, 38.3 ± 9.6% of them disappeared during the 1-min period of TBS (yellow arrowheads in Fig. 3 C and D, and yellow open circles in Movie S2). In contrast, those BDNF-QDs not colocalized with PSD95-GFP puncta disappeared during the 12-min period in an apparently random manner uncorrelated with TBS (red arrows in Fig. 3C ). These results indicate that endosomal BDNF secretion at postsynaptic dendritic sites is much more sensitive to TBS than that occurred at nonsynaptic sites.
Dependence on Ca 2+ Influx and Glutamate Receptor Activation. To examine whether stimulation-induced release of BDNF-QDs depends on Ca 2+ influx, we perfused the culture with extracellular solution containing 20 μM Cd 2+ , which blocks plasma membrane Ca 2+ channels, during the imaging period. For BDNFQDs colocalizing with PSD95-GFP puncta, we found that the percentage of BDNF-QD release at PSD95 + sites during TBS was reduced to a low level similar to that found at PSD95
− sites, and similar to that found before and after TBS (Fig. 3E) . Thus, Ca 2+ entry in response to neuronal activity is required for the exocytosis of BDNF-QD-containing vesicles at postsynaptic sites.
We also examined the contribution of AMPA and NMDA subtypes of glutamate receptors, which are likely to be activated because of firing of both pre-and postsynaptic neurons in response to TBS. When either AMPA or NMDA receptors were blocked with 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or D-(−)-2-amino-5-phosphonopentanoate (D-APV), respectively, the percentages of BDNF-QD release at PSD95 + sites during TBS was reduced to a low level similar to that found for the Cd 2+ treatment (Fig. 3E) . Blocking both AMPA and NMDA receptors had the same effect as blocking either type of glutamate receptors. These results support the notion that Ca 2+ influx through NMDA receptors, whose activation is facilitated by membrane depolarization because of AMPA receptor activation, is essential for activity-induced release of BDNF-QDs at postsynaptic dendritic sites.
Activity-Induced Secretion Occurred at Syt6
+ Sites. Synaptic vesicle fusion shares a common SNARE-mediated fusion mechanism with other forms of neurosecretion that involves Syt and Cpx (32) . To examine whether a specific member of the Syt family is involved in activity-dependent secretion of endocytosed BDNF at postsynaptic sites, we cloned Syt1, Syt4, Syt6, Syt7, Syt9, Syt11, Syt12, and Syt17 from rat embryonic day 19 hippocampi (Table  S1 ) and expressed various GFP-tagged Syt isoforms individually in dissociated hippocampal neurons. Among these isoforms, Syt4, Syt6, Syt9, and Syt12 were expressed in both the axon and dendrites; Syt1, Syt7, and Syt17 were found mainly in the axon; and Syt11 was mainly expressed in dendrites. We found that Syt17-GFP exhibited the highest percentage of juxtaposed colocalization with PSD95 puncta (27.8 ± 4.3%) (Fig. S5) , suggesting its presynaptic localization. Moreover, Syt6-, Syt9-, and Syt12-GFP showed an intermediate value (10-12%), and Syt1-, Syt4-, and Syt11-GFP exhibited lowest colocalization (<5%) with PSD95 puncta.
After exposing 12-16 DIV neurons expressing one of the eight Syt-GFPs to BDNF-QDs for 1 h, time-lapse imaging was performed (for 12-min observation with 1-min TBS) to examine BDNF-QD release at sites with and without colocalization of a distinct isoform of Syt-GFP expressed in the neuron. Among eight groups, we found that the percentage of endocytosed BDNF-QDs that colocalized with Syt6-GFP puncta was the highest (Fig. 4 A and B) . In addition, there was significantly more overall release of BDNF-QDs from Syt6-GFP-expressing neurons (13.6 ± 2.4%). The percentage of BDNF-QD release at Syt6-GFP sites was also much higher during the TBS period (37.8 ± 9.9%) (Fig. 4 C and D) than that occurred before or after TBS. Furthermore, no significant TBS-related release of BDNFQDs was observed at sites showing Syt1, Syt4, Syt9, and Syt12 puncta (Fig. 4E) . Thus, BDNF-QDs associated with Syt6 at the dendrite were released in an activity-dependent manner, suggesting that Syt6 acts as the specific Ca 2+ -sensor for promoting the exocytosis of BDNF-containing endosomes.
Syt6 Knockdown Impaired Activity-Induced Postsynaptic BDNF-QD Release. To further explore the role of various Syt isoforms in BDNF-QD release, we performed loss-of-function experiments in cultured hippocampal neurons using specific siRNAs against the expression of four Syt isoforms Syt4, Syt6, Syt11, and Syt12 that were found to be localized to dendrites (see above). The knockdown efficiency of siRNA vectors targeting these four Syt isoforms was confirmed in cultured 293T cells by Western blotting and immunostaining (Figs. S6B and S7 B-D and F). Downregulation of endogenous Syt4 and Syt6 in hippocampal neurons respectively by siRNA against Sy4 (siSyt4) and by either one of the two forms of siRNA against Syt6 (siSyt6 a or siSyt6 b ) was further verified by immunostaining (Figs. S6C and S7 E and G). Next, we transfected DIV 5-6 neurons with siSyt4, siSyt6, siSyt11 or siSyt12 together with PSD95-GFP, and examined TBSinduced release of BDNF-QDs on 12-16 DIV. We found that the percentage of BDNF-QD release at PSD95-GFP + sites during TBS was reduced to the basal level in neurons transfected with either siSyt6 a or siSyt6 b ( Fig. 5 B and C) . In contrast, none of the neurons transfected with siSyt4, siSyt6 s (scramble sequence of siSyt6 b ), siSyt11, siSyt12, or the control vector UI4 had any significant effect on TBS-induced release at PSD95
+ sites (Fig. 5 C and D) . Furthermore, the knockdown effect of siSyt6 b could be prevented by coexpressing siSyt6 b -resistant Syt6 CDS (Fig. 5C ). Thus, specific down-regulation of Syt6 abolished activity-driven release of BDNF-QDs at postsynaptic sites. These findings further support the notion that Syt6 is the isoform specifically involved in regulating activitydependent secretion of endocytosed BDNF at postsynaptic sites.
Activity-Induced Secretion of Endogenously Synthesized BDNF. Recently it was reported that Syt4 is localized to vesicles containing endogenously synthesized BDNF, which is secreted from both the axon and dendrites in response to neuronal depolarization (33) . To further investigate whether the mechanism regulating the release of endocytosed BDNF also applies to endogenously synthesized BDNF, we transfected the cultured hippocampal neurons with BDNF-EGFP fusion protein to visualize BDNF release events upon electrical stimulation (34) and examined the effects of overexpression or knockdown of Syt4 or Syt6. We transfected Syt4, Syt6, siSyt4, or siSyt6 together with BDNF-EGFP into DIV 5-6 neurons, and examined TBS-induced release of BDNF-EGFP by time-lapse imaging (at sampling rate of 0.2 Hz) on 13-16 DIV. We found that many BDNF-EGFP puncta in dendrites that were visible before TBS exhibited a reduction of fluorescence upon stimulation, indicating the exocytosis of BDNF-EGFP-containing vesicles (Fig. 6 A and B and Movie S3). Elevation of Ca 2+ during TBS was simultaneously monitored together with the reduction of EGFP fluorescence, which reached the maximum (peak) at the end of TBS (0-30 s after TBS) (Fig. 6C) . Moreover, knockdown of Syt4 increased, whereas overexpression decreased the secretion of BDNF-EGFP induced by TBS, suggesting Syt4 inhibits BDNF-EGFP secretion in dendrites (Fig. 6 D-F) . In contrast, overexpression or knockdown of Syt6 had no significant effect on TBS-induced secretion of BDNF-EGFP. Together, these experiments demonstrate that Syt4 and Syt6 play specific regulatory function for the secretion of endogenously synthesized BDNF and endocytosed BDNF, respectively, and their regulatory actions are opposite: Syt4 inhibits and Syt6 promotes the secretion.
Complexin Down-Regulation Impaired Activity-Dependent Secretion.
To determine whether Cpx is involved in activity-dependent secretion of endocytosed BDNF, we examined the TBS-induced release of BDNF-QDs in Cpx1/2 knockdown neurons. When cultures each for all Syt1, -4, -6, -9, -12; 2 cultures for Syt11). Error bars, SEM (*P < 0.01 by paired t test).
DIV 5-6 hippocampal neurons were transfected with a micro-RNA-based siRNA vector (35) , siCpx, together with vector expressing PSD95-GFP, we found that immunostaining of endogenous Cpx1/2 was down-regulated efficiently in these neurons on 13-15 DIV, but PSD95-GFP puncta were similar to that in control untransfected cells (Fig. 7 A and B) . The overall percentage of BDNF-QD release during the 16-min observation period increased by twofold (Fig. 7C) . However, release of BDNFQDs located at the PSD95-GFP + site in Cpx knockdown neurons was reduced during the TBS period (Fig. 7D ). This siCpx effect was prevented by simultaneous coexpression of a siRNA-resistant full-length Cpx1 (Cpx WT ), but not by a mutant form of Cpx1 (Cpx 4M ) that is unable to bind SNARE complexes. These results indicate that Cpx1 is required for activity-dependent exocytosis of BDNF-QDs at postsynaptic sites, but serves as a "clamp" to prevent spontaneous exocytosis of docked endosomes, reminiscent of its role in regulating synaptic vesicle secretion (36) .
To test whether Cpx is involved in activity-induced secretion of endogenously synthesized BDNF, we transfected the cultured hippocampal neurons with both the BDNF-EGFP fusion protein and siCpx, and examined TBS-induced release of BDNF-EGFP on 12-16 DIV. The Cpx knockdown decreased the reduction of BDNF-EGFP fluorescence induced by TBS (Fig. 7 E and F) , suggesting that Cpx inhibits BDNF-EGFP secretion in dendrites. This effect was rescued by simultaneous expression of a siRNAresistant Cpx1 (siCpx + Cpx WT ), but not by the mutant Cpx 4M . Thus, consistent with the influence of Cpx on the BDNF-QD exocytosis, these results demonstrate that Cpx is required for the secretion of endogenously synthesized BDNF.
Discussion
It is generally assumed that exocytosis of BDNF-containing postGolgi granules represents the main pathway for providing synapsemodulating BDNF. In this study, we found that extracellular BDNF-QDs could be endocytosed by cultured hippocampal neurons in a TrkB-dependent manner (Fig. 1) . The endocytosis of BDNF-QDs was preferentially localized to postsynaptic sites on the dendrite, and depolarization facilitated the endocytic process (Fig. S3) . Repetitive extracellular stimulation of the culture in the form of TBS greatly increased the release of endocytosed BDNF-QDs only at PSD95 + postsynaptic sites (Fig.  3D) , and this release requires the activation of synaptic AMPA and NMDA receptors (Fig. 3E) . Among various isoforms of Syt examined, we found that TBS-induced release of BDNF-QDs was significantly facilitated by overexpression of only Syt6 (Fig. 4 C-E) and inhibited by knockdown of only Syt6 (Fig. 5 B-D) . Interestingly, Syt6 does not regulate activity-induced secretion of endogenously synthesized BDNF (Fig. 6 D-F) . Further studies showed that the Cpx1/2 facilitated activity-induced release of BDNF-QDs (Fig. 7D ), but inhibited overall activity-independent BDNF-QD release (Fig. 7C) , consistent with that found for synaptic vesicle exocytosis. Taken together, these results delineate a novel endocytic pathway for providing activity-dependent BDNF secretion at the synapse and its distinct regulatory mechanism (Fig. 8) .
Uptake, Transport, and Localization of BDNF-QDs. We have used brief incubation of cultured neurons with BDNF-QDs to induce endocytic uptake of BDNF-QDs, and fluorescence imaging was performed within 16 min after clearance of extracellular BDNFQDs. Based on the relatively random distribution of cytoplasmic BDNF-QDs in all dendritic branches and the slow rate of axonto-dendrite transport of BDNF-QDs, because of prolonged interruption after their arrival at the soma, we inferred that BDNF-QD uptake occurs at both the axon and dendrites. Furthermore, because most BDNF-QDs that colocalized with the postsynaptic marker PSD95 were immobile, BDNF-QD-containing endosomes may form either directly at postsynaptic sites or at extrasynaptic sites, but rapidly became trapped at the synapse.
Postsynaptic BDNF uptake and accumulation of BDNF-containing endosomes are particularly relevant for synaptic modulation. Because BDNF-containing endosomes are likely to be biochemically active (12-15), they could exert prolonged localized action of BDNF-TrkB signaling in the postsynaptic cytoplasm. Mobile endosomes could also spread BDNF-TrkB signals in the extrasynaptic region. Given the small net translocation of mobile BDNF-QDs observed along the dendrite, dendrite-toaxon transport is likely to be very limited. On the other hand, studies using compartmentalized multiwell culture systems have shown that BDNF-QDs endocytosed at axonal terminals were found in the dendrite at a later time (37) , indicating the existence of axon-to-dendrite transport. This finding is consistent with the in vivo findings that BDNF applied in the developing Xenopus optic tectum results in retrograde potentiation of bipolar cell inputs to the retinal ganglion cell in an axonal transportdependent manner (38) , and LTP induced by TBS at retinotectal synapses exhibited BDNF-dependent retrograde spread to bipolar cell-retinal ganglion cell synapses (39) . Retrograde transport of BDNF-containing endosomes and secretion of endosomal BDNF at the dendrite thus provides a mechanism by which activitydependent modulation of output synapses of a neuron could exert a coordinated modulation of the input synapses at its dendrites both pre-and postsynaptically.
With respect to synaptic localization of BDNF-QDs, we found that 15.6 ± 1.6% of BDNF-QDs were located at immunostained PSD95 + sites (Fig. 1D ) and 17.2 ± 1.9% of BDNF-QDs colocalized with PSD95-GFP puncta (Fig. 3C) along the dendrite after a brief incubation (10 min) of cultured neurons with BDNF-QDs. These percentages were higher than that expected if endocytosed BDNF-QDs were randomly distributed along the dendrite, because the area occupied by the PSD95-GFP puncta along the dendrite was only about 7.8 ± 0.5% (Fig. S3C) . This finding suggests that endocytosed BDNF-QDs showed some preferential localization to the postsynaptic sites in the dendrite. In experiments with prolonged incubation (60 min) of cultured neurons with BDNF-QDs, however, we found only about 9.5% of BDNF-QDs colocalized with PSD95-GFP sites (Fig. 3B) . This may be caused by lateral redistribution of endocytosed BDNFQDs over the 1-h period. To avoid photodamage, imaging time in our experiments was kept within 30 min. This limited time window has prevented us from following individual BDNF-QDs from their endocytosis to subsequent activity-induced release. Thus, we were unable to directly determine whether BDNF-QD-containing endosomes formed at postsynaptic sites may be transported to other dendritic locations for their exocytosis.
Regulatory Functions of Syt and Cpx. Our results showed that TBS promotes the release of BDNF-QDs at PSD95 + postsynaptic sites, but had no effect on the release at extrasynaptic sites, where Ca 2+ elevation as a result of synaptic activation will be largely dissipated. In the absence of applied electrical stimulation, spontaneous release of BDNF-QDs may occur through a fusion mechanism that requires a Syt isoform functional to the resting level of cytoplasmic Ca
2+
. Recent studies have shown that synchronous and asynchronous phases of neurotransmitter release in hippocampal neurons are selectively regulated by Syt1 and Syt7, respectively, with fast Ca 2+ -dependent release facilitated by Syt1 and slower form of Ca 2+ -triggered release mediated by Syt7, whose function is normally occluded by Syt1 (40) . Similar dual Syt regulation may also operate for the secretion of endosomal BDNF in the present case. However, it remains possible that the lack of siRNA knockdown effect on extrasynaptic release of BDNF-QDs was simply because of the low frequency of extrasynaptic release events that rendered the effect of siRNAs undetectable.
Our present results showed that the overall release of endocytosed BDNF-QDs from the dendrite is elevated after downregulation of Cpx1/2. The elevation could be attributed to the increase in spontaneous activity-independent release, because TBS-induced release at postsynaptic sites was greatly reduced. This finding agreed with the notion that Cpx binding to SNARE proteins serves as a clamp to prevent spontaneous fusion of docked vesicles (27, 36) , and removal of the clamp in response to activity requires the action of the Ca 2+ -sensing Syt (41) . Further support to the idea that Cpx plays a role in postsynaptic exocytosis comes from the finding that postsynaptic Cpx regulates AMPA receptor delivery to synapses during LTP (42) . In the present study, Syt6 is the Ca 2+ sensor that specifically promotes the fusion of BDNF-containing endosomes at postsynaptic sites.
The role Syt6 plays in the activity-induced release of BDNFQDs is opposite to that of Syt4 in the secretion of BDNF-containing secretory granules. In hippocampal neurons and Syt4 knockout mice, Syt4 was found to inhibit depolarization-evoked BDNF release in both axons and dendrites (33) . This result is in agreement with our finding that knockdown of Syt4 increased and overexpression decreased the activity-induced secretion of BDNF-EGFP (Fig. 6 D-F) . Our study also showed that Syt6 promotes activity-induced release of BDNF-QDs, but the effect on spontaneous release of BDNF-QDs was not detected, possibly because of the low frequency of spontaneous release events. Furthermore, overexpression and knockdown of Syt6 elevated and abolished TBS-induced BDNF-QD release, respectively, without affecting TBS-induced secretion of BDNF-EGFP. The distinct actions of Syt6 and Syt4 may be attributed to the structural difference between the two proteins. Both Syt4 and Syt6 are composed of a short intravesicular sequence at the amino terminal, a transmembrane region, a central linker sequence, and two carboxyl-terminal C2-domains known as C2A and C2B (43) . In Syt6, the C2-domains were predicted to bind two to three Ca 2+ ions via four to five acidic residues in two flexible loops. In contrast to Syt6, the C2A domain of Syt4 lacks the canonical aspartate residues required for Ca 2+ binding, and the C2B-domain is unable to bind Ca 2+ although it includes all of the requisite Ca 2+ -binding sequence (44) . These structural differences may result in differential Syt binding to endosomes vs. secretary granules and to SNARE proteins, as well as differential Ca 2+ sensitivities for activity-induced exocytosis of these two types of vesicles. Further characterization of the Ca 2+ -dependence of the exocytosis process may also reveal neuronal activity patterns that are required for triggering BDNF secretion via these two different pathways.
Although we have observed endocytosed BDNF-QDs at the axon ( Fig. 1 B-E) , the total number was much lower than that found at the dendrite. We have thus focused our attention on BDNF-QD secretion at the dendrite. Studies using cultured hippocampal neurons expressing fluorescently tagged-BDNF have shown BDNF secretion at both axons and dendrites (45, 46) . However, BDNF and its propeptide have been found in presynaptic dense core vesicles, but not in the postsynaptic dendrites of the adult mouse hippocampus (6), suggesting an anterograde mode of action of BDNF. Previous work has shown that extracellular BDNF released by either pre-or postsynaptic neurons could be recycled back to the synaptic sites via binding to TrkB receptors on the dendrites of postsynaptic neurons (46, 47) . In the present work, we further showed that BDNF could be internalized and released at postsynaptic sites via physiologically Fig. 8 . A diagram illustrating the secretion, uptake, and trafficking of BDNF at excitatory synapses. Post-Golgi granules containing BDNF are known to be the major source of BDNF secreted at the synapse. Binding of secreted BDNF to TrkB receptor leads to endocytic uptake of BDNF-TrkB complexes into "signaling endosomes" by either pre-or postsynaptic neuron. Synaptic activation could result in the exocytosis of not only BDNF-containing granules, but also endosomes containing endocytosed BDNF, in a manner requiring the activation of synaptic AMPA and NMDA receptors. Distinct from the Syt4 that is required for exocytosis of BDNF-containing post-Golgi granules, Syt6 is essential for activity-induced exocytosis of BDNF-containing endosomes. Endocytosed BDNF at postsynaptic dendrites may undergo local exocytosis for reuse near the uptake sites, whereas BDNF-containing endosomes formed by axonal terminals may undergo long-range retrograde transport to somatic and dendritic sites of the presynaptic neuron.
relevant TBS. Indeed, extracellularly provided recombinant BDNF has been found to promote late-LTP in the absence of postsynaptic synthesis at Schaffer collateral-CA1 synapses (16) . Thus, endosomes containing BDNF could serve as secondary storage sites in addition to endogenous BDNF-containing secretory granules, available for future activity-induced secretion and synaptic modulation.
Materials and Methods
For time-lapse imaging of BDNF-QD, 0.5 μL of 1 μM biotinylated BDNF (19) was incubated with 0.5 μL of 1 μM Qdot655 streptavidin conjugate (Invitrogen) at 4°C overnight to form the BDNF-QD complex. DIV 12-16 hippocampal neurons were incubated in an extracellular solution with 2% BSA containing 1 or 0.2 nM BDNF-QD for 10 or 60 min, respectively. Coverslips with BDNF-QD-loaded cells were transferred to a field stimulation chamber in a solution containing 4 μM QSY 21 carboxylic acid, succinimidyl ester (48) or NIS-Elements microscope imaging software (Nikon Instruments) during TBS (12 trains at 5-s intervals, each train consisting of five 5-Hz bursts of five 2-ms pulses at 100 Hz). After acquisition, the images were processed for viewing and analyzed with NIH ImageJ software.
Other detailed experimental procedures of vector construction, cell cultures, immunostaining, preparation of BDNF-QDs, electrical stimulation, time-lapse imaging, and statistical analysis are included in SI Materials and Methods. All animal protocols were approved by the Animal Care and Use Committee of University of California, Berkeley.
ACKNOWLEDGMENTS. We thank Drs. D. L. Turner for providing siRNA vectors (UI4-puro and UI4-GFP) and T. C. Südhof for providing complexin knockdown and rescue constructs (siCpx + Cpx1 4M and siCpx + Cpx1 WT ). This work was supported by National Institutes of Health Grant NS 036999 (to M.-m.P).
Supporting Information
Wong et al. 10 .1073/pnas.1511830112 SI Materials and Methods Vector Construction. Full-length synaptotagmin genes were amplified by PCR from the cDNA of rat embryonic day 19 hippocampi using high-fidelity DNA polymerase (Roche) with various appropriate primer pairs (Table S1 ) and were cut with appropriate restriction enzymes before being ligated into pUS2-GFP to give pSyt1-GFP, pSyt4-GFP, pSyt6-GFP, pSyt7-GFP, pSyt9-GFP, pSyt11-GFP, pSyt12-GFP, and pSyt17-GFP. Protocols of Chung et al. (1) were used to construct the microRNA mimics. DNA fragments containing sequences of complexin or synaptotagmins were cloned into vectors UI4-puro-SIBR or UI4-GFP-SIBR to produce siCpx, siSyt4, siSyt5, siSyt6, siSyt11, and siSyt12. All constructs were verified by restriction enzyme mapping and sequencing. For BDNF-EGFP experiments, we used a Gal4-UAS bipartite system to drive the expression of BDNF-EGFP, as described previously (2, 3) .
Cell Culture and Transfection. Low-density cultures of dissociated embryonic hippocampal neurons were prepared as described previously (4) . Briefly, hippocampi were removed from embryonic rats (embryonic days 19-20) of a Sprague-Dawley pregnant rat and treated with trypsin for 10 min at 37°C, followed by gentle trituration. Animal protocols were approved by the Animal Care and Use Committee of University of California, Berkeley. The dissociated cells were plated at a density of 2,500-3,000 cells per square centimeter on poly-L-lysine-coated glass coverslips. The culturing medium was MEM (Invitrogen) supplemented with 5% (vol/vol) FBS (Gemini), MITO + serum extender (BD Biosciences), Gem21 (Gemini), 20 μM glucose, and glutamax (Invitrogen). After 4 d, the culture medium was changed to Neurobasal (Invitrogen) supplemented with Gem21 and glutamax. We used pyramidal neurons on 12-16 DIV. Cells were transfected on 5-6 DIV using Lipofectamine 2000 (Invitrogen) in Opti-MEM 1 medium (Invitrogen) according to the manufacturer's instructions.
Immunofluorescence Staining. Cells were fixed with 4% (wt/vol) paraformaldehyde and permeabilized with 0.5% Triton X-100. After being blocked with 3% (wt/vol) BSA and 5% (vol/vol) normal goat serum, cells were incubated with primary antibodies overnight at 4°C. The primary antibodies used were as follows: anti-Syp (clone SY38, Millipore Bioscience Research Reagents), anti-PSD95 (clone 6G6-1C9, Millipore Bioscience Research Reagents), anti-Smi-312 (Covance), anti-MAP2 (Novus), anticomplexin 1/2 (Synaptic System), anti-Syt4 (Synaptic Systems), anti-Syt6 (Neuromab), and anti-EEA1 (Abcam). The preparation was washed with PBS and incubated with secondary antibodies conjugated with Alexa 488, Alexa 555 (Invitrogen), or Cy5 at room temperature. The cells were finally washed with PBS and imaged with wide-field epi-fluorescence microscope (Olympus) equipped with a 60× (NA 1.10 W) water-immersion objective.
Western Blotting. Transfected cells were washed once with PBS and dissolved in radioimmunoprecipitation assay lysis buffer (20 mM Hepes, pH 7.8, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100, 50 mM NaF, 1 mM DTT, and protease inhibitor mixture). The cell lysates were cleared by centrifugation at 13,000 × g for 10 min, and the supernatants were used for Western blotting analysis. The protein concentration was determined using a BCA kit (Pierce). For Western blotting analysis, equal amounts of cell lysates were subjected to SDS/PAGE and transferred to polyvinylidene difluoride membranes. The membrane was blocked with 5% (wt/vol) skimmed milk and probed with the primary antibody at 4°C overnight. The primary antibodies used were as follows: anti-c-myc (A-14, Santa Cruz Biotechnology) and anti-β-actin (cell signaling). After the membrane was washed and incubated with HRP-conjugated secondary antibodies at room temperature for 1 h, it was developed with an ECL kit (GE Healthcare).
Preparation of BDNF-QDs. For BDNF-QD imaging, 0.5 μL of 1 μM biotinylated BDNF (5) was incubated with 0.5 μL of 1 μM Qdot655 streptavidin conjugate (Invitrogen) at 4°C overnight to form the BDNF-QD complex. To separate BDNF-QD complexes from free BDNF-biotin in the mixture, we further purified BDNF-QDs by a Centricon centrifugal filter device (Ultracel YM-100 membrane, Millipore) (Fig. S1 , Left, right lane). To ensure that BDNF-QDs remain intact after internalization, the TrkB-GFP plasmid was transfected into HEK293T cells, which did not express endogenous TrkB. After 10 nM BDNF-biotin or purified BDNF-QD was applied to transfected cell culture, cell lysates were harvested and subjected to Western blot by antibiotin, anti-Flag, or anti-β-tubulin antibodies.
To clearly distinguish and trace the individual/single BDNF-QD particle, DIV 12-16 hippocampal neurons were incubated in an extracellular solution with 2% (wt/vol) BSA and various concentrations of BDNF-QDs for 30 min and we then performed timelapse imaging in the presence of QSY21. The number of endocytosed BDNF-QDs observed in the dendrite or axon increased significantly with increasing BDNF-QD concentration in the range of 0.02-1.6 nM. We detected no significant change in the pattern of QD distribution or movement at different BDNF-QD concentrations. The distance between adjacent BDNF-QDs under 0.2 nM, a concentration that induced a robust neurite elongation in cultured rat hippocampal neurons, averaged 5-10 μm, which could be clearly discriminated (Fig. S2 B-D) . Therefore, we have treated hippocampal neurons with low concentration of BDNF-QD at either 1 nM BDNF-QD for 10 min or 0.2 nM BDNF-QD for 60 min throughout our experiments.
Electrical Stimulation and Time-Lapse Imaging of BDNF-QDs. Coverslips with transfected cells were loaded into a custom-made field stimulation chamber and mounted on the stage of an Olympus upright microscope with a 60× (NA 1.10) water-immersion objective. Cells were perfused at 200 μL/min with a normal extracellular solution: 145 mM NaCl, 3 mM KCl, 3 mM CaCl 2 , 2 mM MgCl 2 , 8 mM glucose, and 10 mM Hepes (pH 7.2-7.4) warmed at 30-32°C using a temperature controller (TC-344B; Warner Instruments). Cells were illuminated with a 300W xenon arc lamp (Lambda LS, Sutter Instruments) with neutral density filter attenuation. Extracellular field stimulation was performed via two parallel platinum wires, yielding fields of 10-15 V/cm. Image acquisition and electrical stimulation were synchronized by Master-8 (A.M.P.I.). TBS comprised 12 trains at 5-s intervals, each train consisting of five 5-Hz bursts of five 2-ms pulses at 100 Hz. The effectiveness of stimulation was assessed by fluorescence Ca 2+ imaging. Hippocampal neurons were incubated in an extracellular solution containing 2 μM Calcium Orange (Invitrogen) for 30 min and then washed. The filter set for Calcium Orange comprised a 556/20 nm excitation filter, a 595 nm DRLP dichroic mirror, and a 630/95 nm emission filter (Semrock). Timelapse images were collected at 0.5 Hz with a 14-bit EMCCD camera (iXonEM+ DU897, Andor).
For time-lapse imaging of BDNF-QD, 0.5 μL of 1 μM biotinylated BDNF (5) was incubated with 0.5 μL of 1 μM Qdot655 streptavidin conjugate (Invitrogen) at 4°C overnight to form the BDNF-QD complex. DIV 12-16 hippocampal neurons were incubated in an extracellular solution with 2% (wt/vol) BSA containing 1 or 0.2 nM BDNF-QD for 10 or 60 min, respectively. Coverslips with BDNF-QD-loaded cells were transferred to a field stimulation chamber in a solution containing 4 μM QSY 21 carboxylic acid, succinimidyl ester (QSY21, Invitrogen). The filter set for observing PSD95-GFP, Syp-GFP, or BDNF-EGFP comprised a 480/17-nm excitation filter, a DA/FI/TR three-band dichroic mirror, and a 525/50-nm emission filter. The filter set for BDNF-QD included a 470/20-nm excitation filter, a DA/FI/ TR three-band dichroic mirror, and a 655/15-nm emission filter. The filters were installed in filter wheels and controlled by an optical filter changer (Lambda 10-2, Sutter Instrument). Timelapse images were acquired (acquisition time, 200 ms) at 0.2 Hz with a 14-bit EMCCD camera controlled by Micro-Manager (6) or NIS-Elements microscope imaging software (Nikon Instruments) during stimulation, delivered as above.
Image and Statistical Analysis. After acquisition, the images were processed for viewing and analyzed with NIH ImageJ software. For the colocalization analyses, images were acquired with identical exposure and gain settings. Channels were thresholded separately to include all recognizable puncta of either GFP fusion protein or the result of immunefluorescent staining. BDNF-QDs were identified as particles. The percentage of colocalization was determined as the percentage of the total number of BDNF-QD particles that overlapped with the thresholded area of the corresponding channel. For the colocalization study of BDNF-QD and BDNF-EGFP, images were analyzed using ImageJ/FIJI plugin Coloc_2 (7) . The background fluorescence of BDNF-EGFP was used as a mask to exclude the signal outside the neuron. The Pearson's correlation coefficient was determined as Pearson's R-value above the automatic threshold. For the analysis of BDNF-QD release, axon and dendrite segments of interest were selected and linearlized to generate kymographs from time-lapse images. The y axis of the kymographs represents recording time, and the x axis represents the length (micrometer) of the axonal or dendritic segment images. The time point of BDNF-QD release was determined as the corresponding time to the end point of BDNF-QD trajectory on the kymograph. For the analysis of BDNF-EGFP fluorescence change, a region of interest was circled over the targeted BDNF-EGFP puncta observed on the dendrite of the recorded neuron. To cancel out possible variation of expression levels of BDNF-EGFP and image acquisition conditions among different preparations, we presented data as normalized fluorescence changes (ΔF/F 0 ), in which fluorescence changes (ΔF) at a given time were divided by the average baseline fluorescence (3 min) before stimulation (F 0 ). Statistical significance for all quantitation was determined by Student's t test, paired t test or one-way ANOVA and post hoc analysis. Summary data are given as means ± SEM. To separate BDNF-QD complexes from free BDNF, the mixture was loaded to a Centricon centrifugal filter devices (Ultracel YM-100 membrane; Millipore) and eluted with 20 mM Hepes buffer (pH 7.2) (right lane). All samples were subjected to Western blot by anti-biotin antibody. (Right) HEK293T cells that did not express endogenous TrkB were transfected with a TrkB-GFP plasmid. After 10 nM BDNF-biotin or purified BDNF-QD was applied to transfected cell culture, cell lysates were harvested and subjected to Western blot by antibiotin, anti-Flag, or anti-β-tubulin antibodies. Binding and internalization of BDNF-biotin or BDNF-QD, which remained intact, was specific to the TrkB-GFP transfected cells as shown in the right two lanes. There was no BDNF internalization in the nontransfected cells after 2-h incubation (left two lanes). 
